Back
Galectin Therapeutics, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
49
GALT
Galectin Therapeutics, Inc.
Last Price:
$6.31
Seasonality Move:
33.36%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiGalectin Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Galectin Therapeutics, Inc. has on average historically risen by 42.1% based on the past 23 years of stock performance.
-
Galectin Therapeutics, Inc. has risen higher in 12 of those 23 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.17%
-
Is Galectin Therapeutics, Inc. Stock Undervalued?The current Galectin Therapeutics, Inc. [GALT] share price is $6.30. The Score for GALT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
GALT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Galectin Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Galectin Therapeutics, Inc. has on average historically risen by 42.1% based on the past 23 years of stock performance.
Galectin Therapeutics, Inc. Stock Rating
Sell
49
Galectin Therapeutics, Inc. (GALT)
is a Sell
Is Galectin Therapeutics, Inc. overpriced?
-
Galectin Therapeutics, Inc. has risen higher in 12 of those 23 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.17%
Galectin Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
galectintherapeutics.com
52-Week Data
52-Week High:
6.55
52-Week Low:
0.73
Prediction Charts
Market Cap:
406.2M
Price in USD:
6.30
Volume:
743.9K
Beta:
1.28
Technical Analysis
SMA50:
5.23
SMA100:
4.61
SMA200:
3.11
52-Wk Change:
167.52%
Stock Predictions
-
Is Galectin Therapeutics, Inc. stock public?Yes, Galectin Therapeutics, Inc. is a publicly traded company.
-
What is the Galectin Therapeutics, Inc. stock quote today?The Galectin Therapeutics, Inc. stock price is 6.30 USD today.
-
How to buy Galectin Therapeutics, Inc. stock online?You can buy Galectin Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 5.10 | 5.51 | 5.69 | 5.10 |
| Nov-17 | 5.61 | 6.00 | 6.10 | 5.61 |
| Nov-18 | 5.91 | 6.19 | 6.32 | 5.59 |
| Nov-19 | 6.14 | 5.74 | 6.29 | 5.72 |
| Nov-20 | 5.75 | 5.74 | 6.16 | 5.70 |
| Nov-21 | 5.67 | 5.35 | 6.03 | 5.23 |
| Nov-24 | 5.35 | 5.51 | 5.63 | 5.33 |
| Nov-25 | 5.50 | 5.71 | 5.88 | 5.50 |
| Nov-26 | 5.74 | 5.76 | 5.85 | 5.66 |
| Nov-28 | 5.79 | 5.73 | 5.85 | 5.60 |
| Dec-1 | 5.76 | 5.51 | 5.77 | 5.50 |
| Dec-2 | 5.50 | 5.46 | 5.62 | 5.31 |
| Dec-3 | 5.44 | 5.70 | 5.95 | 5.43 |
| Dec-4 | 5.77 | 6.30 | 6.52 | 5.72 |
Galectin Therapeutics, Inc. Earnings
Galectin Therapeutics, Inc. Earnings Report: Per Share Galectin Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Galectin Therapeutics, Inc. Forecast Revenue Growth
Galectin Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Galectin Therapeutics, Inc. and historical quarterly revenue growth:
* Galectin Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.